A large Australian longitudinal cohort registry demonstrates sustained safety and efficacy of oral medicinal cannabis for at least two years
Table 7
Types of adverse events (possibly) relating to medical cannabis treatment reported by Emyria patients (N = 3,961) across different levels of severity.